The Minnesota Department of Health has reported two variant H3N2 (H3N2v) flu infections, both involving young people who ...
The phase IIIA trials randomized 792 patients ages 12 and older with severe asthma in a 2:1 ratio to depemokimab (100 mg ...
Dr. Steve Caffé is an accomplished industry executive with over 25 years of expertise in global product development and ...
HC Bioscience has appointed Simon Tsang, Ph.D., as Chief Business Officer to lead business development. Takeaway Points HC ...
The combination of belrestotug and dostarlimab significantly improved response rates in patients with previously untreated ...
Bronchoscopic lung volume reduction (BLVR) was associated with sustained improvements in adults with severe emphysema over a 5-year period, based on data from 190 individuals. The LIBERATE study, a ...